1. Home
  2. QURE vs UTL Comparison

QURE vs UTL Comparison

Compare QURE & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • UTL
  • Stock Information
  • Founded
  • QURE 1998
  • UTL 1984
  • Country
  • QURE Netherlands
  • UTL United States
  • Employees
  • QURE N/A
  • UTL N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • UTL Power Generation
  • Sector
  • QURE Health Care
  • UTL Utilities
  • Exchange
  • QURE Nasdaq
  • UTL Nasdaq
  • Market Cap
  • QURE 725.4M
  • UTL 842.0M
  • IPO Year
  • QURE 2007
  • UTL N/A
  • Fundamental
  • Price
  • QURE $14.28
  • UTL $52.09
  • Analyst Decision
  • QURE Strong Buy
  • UTL Hold
  • Analyst Count
  • QURE 10
  • UTL 1
  • Target Price
  • QURE $37.20
  • UTL $55.00
  • AVG Volume (30 Days)
  • QURE 1.2M
  • UTL 74.1K
  • Earning Date
  • QURE 07-31-2025
  • UTL 08-05-2025
  • Dividend Yield
  • QURE N/A
  • UTL 3.44%
  • EPS Growth
  • QURE N/A
  • UTL N/A
  • EPS
  • QURE N/A
  • UTL 2.93
  • Revenue
  • QURE $20,201,000.00
  • UTL $486,900,000.00
  • Revenue This Year
  • QURE N/A
  • UTL $16.37
  • Revenue Next Year
  • QURE $278.91
  • UTL $5.20
  • P/E Ratio
  • QURE N/A
  • UTL $17.87
  • Revenue Growth
  • QURE 6.30
  • UTL N/A
  • 52 Week Low
  • QURE $3.73
  • UTL $50.47
  • 52 Week High
  • QURE $19.18
  • UTL $63.52
  • Technical
  • Relative Strength Index (RSI)
  • QURE 47.07
  • UTL 42.83
  • Support Level
  • QURE $13.65
  • UTL $51.17
  • Resistance Level
  • QURE $14.46
  • UTL $53.29
  • Average True Range (ATR)
  • QURE 0.78
  • UTL 1.15
  • MACD
  • QURE -0.18
  • UTL 0.12
  • Stochastic Oscillator
  • QURE 27.21
  • UTL 39.92

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About UTL UNITIL Corporation

Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.

Share on Social Networks: